Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Teva generic approved

Jan. 31, 1997

CP-0840: Dual-action bradykinin antagonist/mu-opioid agonist from Cortech

Jan. 31, 1997

New MMP inhibitors reported by Warner-Lambert

Jan. 31, 1997

Potent NK1 antagonist reported by Servier

Jan. 30, 1997

Meperidine generic approved

Jan. 30, 1997

Candidate compound identified in Pharmacopeia/Berlex collaboration

Jan. 30, 1997

Clinical trials to begin on novel antidepressant from Korean company

Jan. 30, 1997

Schering Canada and University of Toronto collaborate on Alzheimer research

Jan. 30, 1997

Pilot trial of folic acid in stroke patients

Jan. 30, 1997

Cortex claims AMPA receptor modulators for CNS disorders

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...